Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
“There are fractures that are associated with reduced bone mineral density (BMD) and others that are associated with reduced density of osteocytes, the key cell of bone remodeling.3…” Good
Continue readingAccording to the study talked about in the video, curcumin and diet can slow the progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma. I don’t believe in diets.
Continue readingCan MGUS Patients Prevent full-blown MM with IP6 and Inositol? Jim Thinks So- I believe that I have remained in complete remission from my end-stage Multiple Myeloma since ’99 by living an evidence-based,
Continue reading“…there is a need to better understand the significant heterogeneity in SMM and to identify the patients who benefit the most from early treatment from those who can safely defer treatment.” I
Continue reading“The optimal endpoint for studies evaluating progression from SMM to active MM is OS or a substantial improvement in the quality of life.” For as long as I can remember, conventional oncology
Continue reading“Often, no symptoms (of multiple myeloma) are noticed initially. As it progresses, bone pain, anemia, kidney dysfunction, and infections may occur.” I have recently been diagnosed with asymptomatic
Continue reading“As hyperthermia is nonmyelosuppressive (MGUS) and can potentiate the tumoricidal effects of radiation, chemotherapy, and immunotherapy, its use as part of a multimodality treatment approach is attractive.” Hi
Continue readingIf you are not young, early stage (MM) and low-risk then, according to the research below, your average first remission will be about 2-3 years and your OS will be about the average 5-7 years. Hi David-
Continue reading“…based on 29 cases that progressed to MM or other LP diseases later in life, our study found midlife obesity to be a risk factor for progression among individuals diagnosed with MGUS.” Hi
Continue reading“However, most patients eventually relapse and often demonstrate multiple drug resistance. Therefore there is still an urgent and unmet need to define the molecular mechanisms of resistance for available
Continue readingtreatment of MGUS/SMM patients with curcumin resulted in an improvement in markers of disease progression (i.e., free light-chain ratio (rFLC), paraprotein levels, percentage plasma cells) in some patients
Continue readingA recent update confirmed an overall survival advantage after a median follow-up of more than six years,”How can overall survival be measured in pre-Multiple Myeloma (MGUS, SMM)? The oncologist in
Continue reading